Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mylan Launches Generic Norvasc; 180-Day Exclusivity May Be Moot

This article was originally published in The Pink Sheet Daily

Executive Summary

Pfizer counters by launching an “authorized” generic under its Greenstone brand.

You may also be interested in...



Prescription Drug Sales Up Just 4 Percent In 2007 – IMS Health Report

Generic competition, safety issues and Medicare Part D are factors in decline to 3.8 percent growth from 8 percent in 2006.

Prescription Drug Sales Up Just 4 Percent In 2007 – IMS Health Report

Generic competition, safety issues and Medicare Part D are factors in decline to 3.8 percent growth from 8 percent in 2006.

UCB Seeks FDA Approval For Cimzia In Rheumatoid Arthritis

The biologic, which has yet to obtain a Crohn’s indication in the U.S. and Europe, is backed by efficacy data from three Phase III trials in RA.

Related Content

Topics

UsernamePublicRestriction

Register

PS065802

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel